These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

388 related articles for article (PubMed ID: 14556941)

  • 1. Riluzole suppresses experimental autoimmune encephalomyelitis: implications for the treatment of multiple sclerosis.
    Gilgun-Sherki Y; Panet H; Melamed E; Offen D
    Brain Res; 2003 Nov; 989(2):196-204. PubMed ID: 14556941
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mice overexpressing Bcl-2 in their neurons are resistant to myelin oligodendrocyte glycoprotein (MOG)-induced experimental autoimmune encephalomyelitis (EAE).
    Offen D; Kaye JF; Bernard O; Merims D; Coire CI; Panet H; Melamed E; Ben-Nun A
    J Mol Neurosci; 2000 Dec; 15(3):167-76. PubMed ID: 11303781
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Distinct pathological patterns in relapsing-remitting and chronic models of experimental autoimmune enchephalomyelitis and the neuroprotective effect of glatiramer acetate.
    Aharoni R; Vainshtein A; Stock A; Eilam R; From R; Shinder V; Arnon R
    J Autoimmun; 2011 Nov; 37(3):228-41. PubMed ID: 21752599
    [TBL] [Abstract][Full Text] [Related]  

  • 4. T- and B-cell responses to myelin oligodendrocyte glycoprotein in experimental autoimmune encephalomyelitis and multiple sclerosis.
    Iglesias A; Bauer J; Litzenburger T; Schubart A; Linington C
    Glia; 2001 Nov; 36(2):220-34. PubMed ID: 11596130
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Analysis of gene expression in MOG-induced experimental autoimmune encephalomyelitis after treatment with a novel brain-penetrating antioxidant.
    Gilgun-Sherki Y; Barhum Y; Atlas D; Melamed E; Offen D
    J Mol Neurosci; 2005; 27(1):125-35. PubMed ID: 16055951
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cannabidiol inhibits pathogenic T cells, decreases spinal microglial activation and ameliorates multiple sclerosis-like disease in C57BL/6 mice.
    Kozela E; Lev N; Kaushansky N; Eilam R; Rimmerman N; Levy R; Ben-Nun A; Juknat A; Vogel Z
    Br J Pharmacol; 2011 Aug; 163(7):1507-19. PubMed ID: 21449980
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Limiting multiple sclerosis related axonopathy by blocking Nogo receptor and CRMP-2 phosphorylation.
    Petratos S; Ozturk E; Azari MF; Kenny R; Lee JY; Magee KA; Harvey AR; McDonald C; Taghian K; Moussa L; Mun Aui P; Siatskas C; Litwak S; Fehlings MG; Strittmatter SM; Bernard CC
    Brain; 2012 Jun; 135(Pt 6):1794-818. PubMed ID: 22544872
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mannan-MOG35-55 Reverses Experimental Autoimmune Encephalomyelitis, Inducing a Peripheral Type 2 Myeloid Response, Reducing CNS Inflammation, and Preserving Axons in Spinal Cord Lesions.
    Dagkonaki A; Avloniti M; Evangelidou M; Papazian I; Kanistras I; Tseveleki V; Lampros F; Tselios T; Jensen LT; Möbius W; Ruhwedel T; Androutsou ME; Matsoukas J; Anagnostouli M; Lassmann H; Probert L
    Front Immunol; 2020; 11():575451. PubMed ID: 33329540
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Translocator Protein Ligand PIGA1138 Reduces Disease Symptoms and Severity in Experimental Autoimmune Encephalomyelitis Model of Primary Progressive Multiple Sclerosis.
    Tremolanti C; Cavallini C; Meyer L; Klein C; Da Pozzo E; Costa B; Germelli L; Taliani S; Patte-Mensah C; Mensah-Nyagan AG
    Mol Neurobiol; 2022 Mar; 59(3):1744-1765. PubMed ID: 35018577
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Experimental Autoimmune Encephalomyelitis (EAE) Model of Cynomolgus Macaques Induced by Recombinant Human MOG1-125 (rhMOG1-125) Protein and MOG34-56 Peptide.
    Peng Z; Zhang L; Wang H; He X; Peng X; Zhang Q; Liu H; Rao J; Wang H; Wu J; Sun Y
    Protein Pept Lett; 2018 Feb; 24(12):1166-1178. PubMed ID: 29141529
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Autoimmunity against myelin oligodendrocyte glycoprotein is dispensable for the initiation although essential for the progression of chronic encephalomyelitis in common marmosets.
    Jagessar SA; Smith PA; Blezer E; Delarasse C; Pham-Dinh D; Laman JD; Bauer J; Amor S; 't Hart B
    J Neuropathol Exp Neurol; 2008 Apr; 67(4):326-40. PubMed ID: 18379435
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Chronic relapsing experimental autoimmune encephalomyelitis with a delayed onset and an atypical clinical course, induced in PL/J mice by myelin oligodendrocyte glycoprotein (MOG)-derived peptide: preliminary analysis of MOG T cell epitopes.
    Kerlero de Rosbo N; Mendel I; Ben-Nun A
    Eur J Immunol; 1995 Apr; 25(4):985-93. PubMed ID: 7737302
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Glutathione PEGylated liposomal methylprednisolone (2B3-201) attenuates CNS inflammation and degeneration in murine myelin oligodendrocyte glycoprotein induced experimental autoimmune encephalomyelitis.
    Lee DH; Rötger C; Appeldoorn CC; Reijerkerk A; Gladdines W; Gaillard PJ; Linker RA
    J Neuroimmunol; 2014 Sep; 274(1-2):96-101. PubMed ID: 25037177
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Action of treosulfan in myelin-oligodendrocyte-glycoprotein-induced experimental autoimmune encephalomyelitis and human lymphocytes.
    Weissert R; Wiendl H; Pfrommer H; Storch MK; Schreiner B; Barth S; Seifert T; Melms A; Dichgans J; Weller M
    J Neuroimmunol; 2003 Nov; 144(1-2):28-37. PubMed ID: 14597095
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Opioid growth factor suppresses expression of experimental autoimmune encephalomyelitis.
    Zagon IS; Rahn KA; Bonneau RH; Turel AP; McLaughlin PJ
    Brain Res; 2010 Jan; 1310():154-61. PubMed ID: 19931226
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fc receptors are critical for autoimmune inflammatory damage to the central nervous system in experimental autoimmune encephalomyelitis.
    Abdul-Majid KB; Stefferl A; Bourquin C; Lassmann H; Linington C; Olsson T; Kleinau S; Harris RA
    Scand J Immunol; 2002 Jan; 55(1):70-81. PubMed ID: 11841694
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Methylprednisolone induces reversible clinical and pathological remission and loss of lymphocyte reactivity to myelin oligodendrocyte glycoprotein in experimental autoimmune encephalomyelitis.
    Chan J; Ban EJ; Chun KH; Wang S; McQualter J; Bernard C; Toh BH; Alderuccio F
    Autoimmunity; 2008 Aug; 41(5):405-13. PubMed ID: 18568646
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Myelin oligodendrocyte glycoprotein-specific T and B cells cooperate to induce a Devic-like disease in mice.
    Bettelli E; Baeten D; Jäger A; Sobel RA; Kuchroo VK
    J Clin Invest; 2006 Sep; 116(9):2393-402. PubMed ID: 16955141
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A myelin oligodendrocyte glycoprotein peptide induces typical chronic experimental autoimmune encephalomyelitis in H-2b mice: fine specificity and T cell receptor V beta expression of encephalitogenic T cells.
    Mendel I; Kerlero de Rosbo N; Ben-Nun A
    Eur J Immunol; 1995 Jul; 25(7):1951-9. PubMed ID: 7621871
    [TBL] [Abstract][Full Text] [Related]  

  • 20. IL-6-deficient mice are resistant to the induction of experimental autoimmune encephalomyelitis provoked by myelin oligodendrocyte glycoprotein.
    Okuda Y; Sakoda S; Bernard CC; Fujimura H; Saeki Y; Kishimoto T; Yanagihara T
    Int Immunol; 1998 May; 10(5):703-8. PubMed ID: 9645618
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.